Positron Emission Tomography (PET) Images Using Deep Neural Networks
NCT ID: NCT04140565
Last Updated: 2019-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2019-11-01
2021-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
several studies have used machine learning to produce diagnostic images from low quality images.The goal of our study is to produce diagnostic PET images with 10 seconds acquisition time per bed position using DNN algorithms
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Artificial Intelligence Algorithm Reducing Noise on Fast Whole-body Bone Tomoscintigraphy Acquisitions Recorded by a 360 Degree Cadmium-Zinc-Tellurid Camera
NCT06782438
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881
Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
NCT01873469
Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities
NCT04152928
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
NCT02378337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal of our study is to produce diagnostic PET images with 10 seconds acquisition time per bed position using DNN algorithms developed at the CILAB laboratory in the imaging department of Sheba.
The algorithms were previously successfully validated for the denoising of ultra-low dose chest CT scans, making them suitable for lung cancer screening. The algorithms are based on the locally-consistent non-local means (LC-NLM) algorithm.
The LC-NLM algorithm uses fast approximate nearest neighbors (ANN) to find the most similar high-SNR patch, in a purposely built database, for each noisy patch in the input image (Green et al.) \] We propose to use the recently introduced non-local neural networks (Wang et al.) in order to stack the LC-NLM into a fully trainable, locally-consistent nonlocal block (LC-NLB). The original non-local networks combines the ideas of the classical non-local means (NLM) algorithm (Buades et al.) into a neural network block, which computes the output at a specific position as a weighted sum of the features at all positions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Computational Imaging Lab , Dr. Arnaldo Mayer
UNKNOWN
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Liran Domachevsky
Chair, Department of Nuclear Medicine Sheba Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liran Domachevsky, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba Medical Center Hospital- Tel Hashomer
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-19-6267-LD-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.